ArticleClinical sarcoma research2013
Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.
Article in Clinical sarcoma research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 63 citations in OpenAlex.
- Dermatofibrosarcoma Protuberans (DFSP): Current Treatments and Clinical Trials.Current treatment options in oncology · 2025Review
- Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.Human cell · 2024Article
- Dermatofibrosarcoma Protuberans in a 12-Year-Old Child: A Rare Case.Clinical, cosmetic and investigational dermatology · 2024Article
- Molecular pathways and therapeutic strategies in dermatofibrosarcoma protuberans (DFSP): unravelling the tumor's genetic landscape.EXCLI journal · 2024Review
- Article
- Multi-omic profiling and real time ex vivo modelling of imatinib-resistant dermatofibrosarcoma protuberans with fibrosarcomatous transformation.Human cell · 2023Article
- Dermatofibrosarcoma protuberans challenges: a case series and review of the literature.Journal of medical case reports · 2023Review
- Dermatofibrosarcoma Protuberans in Children.Current treatment options in oncology · 2022Review
- Malignant Superficial Mesenchymal Tumors in Children.Cancers · 2022Review
- Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.Human cell · 2020Article
- Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment.Journal of clinical medicine · 2020Review
- Pulmonary metastases of fibrosarcomatous dermatofibrosarcoma protuberans respond to apatinib-based angiogenesis and chemotherapy: a case report.Annals of translational medicine · 2019Article
- Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.Current treatment options in oncology · 2019Review
- Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.In vitro cellular & developmental biology. Animal · 2019Article
- A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure.OncoTargets and therapy · 2018Article
- Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new.BMC medicine · 2017Review
- Dermatofibrosarcoma protuberans post basal cell carcinoma excision: A case report.International journal of surgery case reports · 2016Article
- Dermatofibrosarcoma protuberans: from translocation to targeted therapy.Cancer biology & medicine · 2015Review
- Dermatofibrosarcoma Protuberans of Lumbar Region with Metastasis to Lung: A Rare Presentation.Journal of clinical and diagnostic research : JCDR · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DFSP is a locally invasive, slow-growing tumor of the subcutaneous tissue that rarely metastasizes but recurs frequently after surgical excision. We report herein a case of highly recurrent, locally invasive DFSP that failed both postoperative radiation therapy and complete trial of Imatinib, but was successfully treated with Sorafenib, which showed unprecedented response.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.